Frank C. Dougherty

Pharmacokinetics and Pharmacodynamics of Intravenous and Subcutaneous Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Chronic Kidney Disease

Iain C. Macdougall, Richard A. Robson, Sylvie Opatrná et al. · Clinical Journal of the American Society of Nephrology · 2006 · 188 citations

Medicine, Pharmacokinetics, Pharmacology +15

Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA

H. Eichstaedt, R. Félix, Frank C. Dougherty et al. · Clinical Cardiology · 1986 · 103 citations · Full text

Medicine, Cardiology, Radiology +14

C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis

Iain C. Macdougall, Rowan G. Walker, Robert Provenzano et al. · Clinical Journal of the American Society of Nephrology · 2008 · 101 citations

Medicine, Pharmacology, Pharmacotherapy +16

Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial

Fernando Carrera, Charmaine E. Lok, Angel de Francisco et al. · Nephrology Dialysis Transplantation · 2010 · 78 citations · Full text

Medicine, Nephrology, Pharmacotherapy +13

Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial

Marian Klinger, Manual Arias, Vassilis Vargemezis et al. · American Journal of Kidney Diseases · 2007 · 74 citations

Medicine, Pharmacology, Pharmacotherapy +13